α-Synuclein in Parkinson's Disease

被引:883
|
作者
Stefanis, Leonidas [1 ,2 ]
机构
[1] Acad Athens, Biomed Res Fdn, Lab Neurodegenerat Dis, Athens 11527, Greece
[2] Univ Athens, Sch Med, Dept Neurol 2, GR-11527 Athens, Greece
来源
关键词
CHAPERONE-MEDIATED AUTOPHAGY; DOPAMINERGIC NEURONAL LOSS; NIGRA PARS COMPACTA; BETA-SYNUCLEIN; WILD-TYPE; DROSOPHILA MODEL; LEWY BODIES; IN-VIVO; INCLUSION FORMATION; MOUSE MODEL;
D O I
10.1101/cshperspect.a009399
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
alpha-Synuclein is a presynaptic neuronal protein that is linked genetically and neuropathologically to Parkinson's disease (PD). alpha-Synuclein may contribute to PD pathogenesis in a number of ways, but it is generally thought that its aberrant soluble oligomeric conformations, termed protofibrils, are the toxic species that mediate disruption of cellular homeostasis and neuronal death, through effects on various intracellular targets, including synaptic function. Furthermore, secreted alpha-synuclein may exert deleterious effects on neighboring cells, including seeding of aggregation, thus possibly contributing to disease propagation. Although the extent to which alpha-synuclein is involved in all cases of PD is not clear, targeting the toxic functions conferred by this protein when it is dysregulated may lead to novel therapeutic strategies not only in PD, but also in other neurodegenerative conditions, termed synucleinopathies.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Familial Parkinson's disease α-synuclein and parkin
    Mizuno, Y
    Hattori, N
    Kitada, T
    Matsumine, H
    Mori, H
    Shimura, H
    Kubo, S
    Kobayashi, H
    Asakawa, S
    Minoshima, S
    Shimizu, N
    [J]. PARKINSON'S DISEASE, 2001, 86 : 13 - 21
  • [22] α-Synuclein in Parkinson's disease: causal or bystander?
    Riederer, Peter
    Berg, Daniela
    Casadei, Nicolas
    Cheng, Fubo
    Classen, Joseph
    Dresel, Christian
    Jost, Wolfgang
    Krueger, Rejko
    Mueller, Thomas
    Reichmann, Heinz
    Riess, Olaf
    Storch, Alexander
    Strobel, Sabrina
    van Eimeren, Thilo
    Voelker, Hans-Ullrich
    Winkler, Juergen
    Winklhofer, Konstanze F.
    Wuellner, Ullrich
    Zunke, Friederike
    Monoranu, Camelia-Maria
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (07) : 815 - 840
  • [23] α-Synuclein in Parkinson's disease and advances in detection
    Chen, Rong
    Gu, Xuan
    Wang, Xiaoying
    [J]. CLINICA CHIMICA ACTA, 2022, 529 : 76 - 86
  • [24] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    [J]. MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9
  • [25] Parkinson's disease biomarkers based on α-synuclein
    Fayyad, Muneera
    Salim, Safa
    Majbour, Nour
    Erskine, Daniel
    Stoops, Erik
    Mollenhauer, Brit
    El-Agnaf, Omar M. A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2019, 150 (05) : 626 - 636
  • [26] α-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease
    Mullin, Stephen
    Schapira, Anthony
    [J]. MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 587 - 597
  • [27] Biomarkers and the Role of α-Synuclein in Parkinson's Disease
    Du, Tingting
    Wang, Le
    Liu, Weijin
    Zhu, Guanyu
    Chen, Yingchuan
    Zhang, Jianguo
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [28] Expression of α-synuclein mRNA in Parkinson's disease
    Papapetropoulos, Spiridon
    Shehadeh, Lina
    Shehadeh, Lina
    [J]. MOVEMENT DISORDERS, 2007, 22 (07) : 1057 - 1059
  • [29] Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
    Fatemeh Nouri Emamzadeh
    [J]. Journal of Molecular Neuroscience, 2017, 62 : 344 - 355
  • [30] Neuropathology The aαsynuclein, central to Parkinson's disease
    Vernet, Agnes
    [J]. BIOFUTUR, 2012, (338) : 8 - 8